NAD+
Nicotinamide Adenine Dinucleotide · NAD
Popular for:Cellular energy, DNA repair, anti-aging, sirtuin activation
45837
Total Studies
14502
Human Studies
Animal
Evidence Level
Not Approved
FDA Status
Overview
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in every living cell, essential for cellular energy production, DNA repair, and activation of sirtuins (longevity-associated proteins). NAD+ levels decline significantly with age — by age 50, levels may be half of what they were at age 20.
While NAD+ precursors like NMN and NR are available as oral supplements, injectable NAD+ provides direct cellular replenishment bypassing the conversion steps required by precursors. IV NAD+ infusions and subcutaneous injections are researched for anti-aging, neurodegeneration, metabolic health, and addiction recovery.
Mechanism of Action
NAD+ serves as a critical coenzyme in mitochondrial electron transport chain reactions (cellular energy production) and as a substrate for enzymes including sirtuins (SIRT1-7), PARPs (DNA repair enzymes), and CD38. By replenishing NAD+ levels, these enzymatic pathways are supported, potentially improving mitochondrial function, genomic stability, and cellular stress responses.
Key Research Benefits
Clinical Evidence Summary
Research Pipeline
45837
Total Studies
14502
Human Studies
NAD+ is a naturally occurring coenzyme, not a drug. IV and injectable forms available through clinics and compounding pharmacies. Oral precursors (NMN, NR) available as supplements. Not FDA-approved as a therapeutic.
Key Studies / PubMed References
45,837 studies found on PubMed · showing top 25 by relevance
View all on PubMedNAD metabolism: Role in senescence regulation and aging.
ReviewChini CCS, Cordeiro HS, Tran NLK, et al. · Aging cell · 2024
PMID: 37424179NADBoosting Strategies.
In VitroRice J, Lautrup S, Fang EF · Sub-cellular biochemistry · 2024
PMID: 39693020The therapeutic perspective of NADprecursors in age-related diseases.
ReviewIqbal T, Nakagawa T · Biochemical and biophysical research communications · 2024
PMID: 38340651Roles of NADin Health and Aging.
Human StudyLautrup S, Hou Y, Fang EF, et al. · Cold Spring Harbor perspectives in medicine · 2024
PMID: 37848251Regulation of and challenges in targeting NADmetabolism.
ReviewMigaud ME, Ziegler M, Baur JA · Nature reviews. Molecular cell biology · 2024
PMID: 39026037Side Effects & Safety
Known Interactions
No curated interaction entry is live for NAD+ yet.
Until the interaction table is fully populated, use the interaction checker and related peptides below to explore adjacent compounds and likely research pairings.
Frequently Asked Questions
Research Disclaimer
This page is for research and educational purposes only. The information presented is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. NAD+ is not approved by the FDA for human therapeutic use. Always consult a qualified healthcare professional before making any health-related decisions. The studies referenced are linked to their original PubMed sources for verification.